Skip to main content
. 2016 Sep 7;5(10):2850–2860. doi: 10.1002/cam4.826

Figure 7.

Figure 7

The elimination of ruthenium‐pyridine complexes from lungs of mice bearing 4T1 mammary carcinoma and treated with doses of NAMI‐A active on lung metastases (n = 3). The dosage regimen was 17.5 mg/kg per day for consecutive 6 days plus 3 days at 1‐day interval. The organs were collected at 24, 72, and 144 h after last administration. (A) The calibration plot of analyses and (B) the biodistribution of Ru in the lungs were detected.